Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 307-317, April 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, H. S.
Right arrow Articles by Sternberg, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, H. S.
Right arrow Articles by Sternberg, S. S.

Actinomycin D Effects on Nucleic Acid and Protein Metabolism in Intact and Regenerating Liver of Rats1

Herbert S. Schwartz, J. E. Sodergren, M. Garofalo and S. S. Sternberg

( Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, New York)

Single, lethal doses of actinomycin D (1 mg/kg) promptly decreased the rate of incorporation of C14-orotate into nuclear ribonucleic acid of liver in intact and hepatectomized rats. The inhibition was transient, despite morphologic changes that appeared at 3 hr., and was fully reversed by 16 hr. in intact liver and partially so in regenerating liver. In regenerating liver, mitotic inhibition was also seen at 1 hr. and became maximal by 16 hr. Thymidine incorporation into deoxyribonucleic acid (DNA) of regenerating liver, though only slightly affected during the first hour, diminished markedly by 16 hr. Tryptophan pyrrolase activity, assayed in homogenates of intact liver, was stimulated in control animals for at least 4 hr. after ether anesthesia and I.V. saline injections; it returned to basal levels at 16 hr. Actinomycin prevented the initial stimulation. Leucine incorporation in protein was not inhibited directly in intact liver; in regenerating liver moderate inhibitions developed slowly. Higher doses of actinomycin (5 mg/kg) inhibited thymidine incorporation in DNA (80% by 1 hr.) and leucine incorporation in protein (30–40% by 4 hr.).

1 This study was aided by Cancer Chemotherapy National Service Center contract SA-43-ph-2445 and grant CA-03192 from the National Cancer Institute, USPHS. A preliminary report was presented in Proc. Am. Assoc. Cancer Research, 5: 57, 1964.

Received 9/17/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.